ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 176 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 4.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $174,854 | +402.2% | 55,159 | +687.3% | 0.00% | – |
| Q2 2023 | $34,820 | -33.6% | 7,006 | -34.0% | 0.00% | – |
| Q1 2023 | $52,423 | +2793.1% | 10,612 | +3584.7% | 0.00% | – |
| Q4 2022 | $1,812 | -99.0% | 288 | -97.7% | 0.00% | – |
| Q4 2021 | $186,000 | +132.5% | 12,460 | +299.9% | 0.00% | – |
| Q3 2021 | $80,000 | -32.8% | 3,116 | -31.5% | 0.00% | – |
| Q2 2021 | $119,000 | -82.9% | 4,550 | -77.0% | 0.00% | -100.0% |
| Q1 2021 | $697,000 | +2930.4% | 19,743 | +2062.4% | 0.00% | – |
| Q4 2020 | $23,000 | -85.3% | 913 | -84.8% | 0.00% | -100.0% |
| Q4 2019 | $156,000 | +721.1% | 6,005 | +751.8% | 0.00% | – |
| Q3 2019 | $19,000 | -5.0% | 705 | -4.7% | 0.00% | – |
| Q2 2019 | $20,000 | +185.7% | 740 | +208.3% | 0.00% | – |
| Q1 2019 | $7,000 | – | 240 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $16,381,000 | 9.53% |
| Wildcat Capital Management, LLC | 2,128,370 | $19,389,000 | 4.96% |
| TPG GP A, LLC | 18,716,306 | $170,506,000 | 2.11% |
| Pier Capital, LLC | 746,669 | $6,802,000 | 0.87% |
| Coastal Bridge Advisors, LLC | 401,929 | $3,662,000 | 0.84% |
| HARBOR CAPITAL ADVISORS, INC. | 92,755 | $845,000 | 0.40% |
| Lombard Odier Asset Management (Switzerland) SA | 501,219 | $4,566,000 | 0.36% |
| Navalign, LLC | 74,271 | $623,000 | 0.26% |
| PDT Partners, LLC | 241,592 | $2,201,000 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 148,804 | $1,356,000 | 0.18% |